Pharmaceutical Industry

Pharmaceutical Industry News

The FDA’s “Orphan Drug” Program is Turning into a Cash Cow For Big Pharma

The intentions behind the Orphan Drug Act of 1983 may have been good ones, but in recent years, it has also been an opportunity for Big Pharma to dodge taxes and make big profits – often at the expense of taxpayers, while providing questionable benefits to patients it was...

Guaranteed, Single-Payer Health Care: It’s Not Just Good for People, It’s Good for Business

Imagine you are running your own company – or perhaps you already do. Would it help if you were relieved of the burden of locating and providing health care benefits for your employees? Do you think that workers who were able to obtain medical care when needed without having...

Good News For The Weekend: a New “Old” Potential Treatment for Autism

Until the introduction of the herbicide glyphosate (the active ingredient in Monsanto's Roundup), autism was a very rare condition that affected one child in 10,000. Over the past forty years, rates of autism have soared to the point that the condition now affects one child in 70.According to...

Alarming New Study Links Anti-Psychotics With Childhood Obesity

A recently-published Canadian study involving children and teens indicates that the use of antipsychotic medications such as Abilify and Risperdal can lead to serious weight problems as early as age two. In the retrospective study (one that investigates past data), researchers examined the records of 147 children between the...

Department of Justice Charges 400 Individuals With Health Care Fraud: One in Four Were Peddling Opioids

This week saw the “largest health care fraud takedown operation” in the nation's history, according to U.S. Attorney General Jeff Sessions. Over 400 people – nearly 60 of whom are licensed physicians or nurse practitioners – have been charged with health care fraud costing American taxpayers $1.3 billion. 120...

A Tale of Two Prescription Meds and How They Illuminate a Big Pharma Scam

Individually, they're pretty inexpensive. Put them together, however, and they become worth almost half a billion dollars to Big Pharma. In the present case, naproxen, a prescription pain reliever marketed under the brand name Aleve, is one of them. The other is esomeprazole, a medication used to treat occasional...

Amidst Controversies Surrounding ADHD Medication Safety, a Pharmaceutical Company Comes Up With “Chewable” Meds. Is This a Good Idea?

At a time when the use and overuse of amphetamine and methylphenidate-based medications among “hyperactive” children is being called into question, a pharmaceutical company known as Neos Therapeutics has managed to win FDA approval for not one, but two new chewable, fruit-flavored ADHD/ADD drugs.As one might imagine, these...

The “Fairness in Class Action Litigation Act” Will Make it More Difficult to Hold Pharmaceutical Companies Accountable

Even when companies like Johnson & Johnson, Bayer, Daichii Sankyo and others are found liable for creating and marketing products that cause injury and death, holding them accountable is difficult.First of all, verdicts against such corporate defendants are frequently appealed – and the appellate process can drag on...

Papantonio: Daily Death Tolls Caused By Big Pharma’s Opioid Epidemic

According to data by the Center for Disease Control, 91 Americans die every day from overdosing on opioids, in the form of both prescription drugs and drugs like heroin. But its that first class – prescription painkillers – that is a major cause for concern. America’s Lawyer Mike Papantonio...

Approval Based On Emotion Rather Than Science: How One Pharma Company Won Expedited FDA Approval for Obscenely Expensive Drug

There are two parts to this tale. One involves a mother who was desperate for a treatment that might keep her sons alive. The other involves the CEO of a pharmaceutical corporation who was equally desperate to pump up the value of his company's stock.Just over a year...